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Abstract
Carbohydrates play significant roles in various biological and pathological
processes such as cancer metastasis and inflammation. They participate in various
signaling pathways and are able to bind to a litany of biological receptors such as
proteins and viruses. Biologists have known for decades that the structures of glycans
change with the onset of cancer and inflammation. Due to these important activities,
carbohydrate sensing has long been a focus of research. One example of such a
carbohydrate sensor is boronic acid-based sensors. Boronic acid-based sensors are of
particular interest due to their selectivity for 1,2- or 1,3-diols. A variety of techniques
have been employed for detection. Two techniques that have rarely been applied are
high-throughput microarray analysis and FRET detection. In this thesis, we present
work based on the development of a boronic acid-based carbohydrate sensor that will
be used for microarray analysis and the development of various fluorophore-tagged
boronic acids as donor/acceptor pairs for FRET detection. Herein, we describe the
design and development of these compounds as well as initial results in their application
for the detection of saccharides involved in important biological properties.
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Chapter 1:
1.1

Design, Synthesis and Studies of Boronic Acid
Based Carbohydrate Receptors

Background and Significance of Carbohydrates in Biological
Processes
Carbohydrates, also known as saccharides, glycans or sugars, play numerous

roles in living organisms. The carbohydrates are divided into four groups:
monosaccharides, disaccharides, oligosaccharides, and polysaccharides. In general,
monosaccharides and disaccharides are simple carbohydrates with low molecular
weight, which are commonly referred to as sugars. Monosaccharides are the simplest
and most basic units of carbohydrates; two units of monosaccharides condense to form
a disaccharide. Even though the nature of carbohydrate nomenclature is complex, the
names of these simple sugars very often end in the suffix –ose. For example, blood
sugar is the monosaccharide glucose, table sugar is the disaccharide sucrose, and milk
sugar is the disaccharide lactose. Oligosaccharides are polymers of sugars containing
typically two to ten units of monosaccharides. In mammalian systems, they are
generally found O- or N-linked to compatible amino acid side chains.1 Polysaccharides
are long carbohydrate chains of repeated monosaccharide units joined together by
glycosidic bonds. Polysaccharides contain at least ten monosaccharide units and can
be branched or linear chains. They are used in the storage of energy in the form of
starch in plants and in the form of glycogen in animals and fungi. In addition,
polysaccharides act as structural components in plants as cellulose and in arthropods
as chitin.2
1

Figure 1.1

Physical structures of cancer-associated glycans
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In living cells, most membrane-associated and secreted proteins contain
appended carbohydrate structures, existing as glycoconjugates of different molecular
configurations such as glycoproteins, glycosaminoglycans, and proteoglycans.3 When
cells are healthy, these various structures play important roles in molecular recognition
at fertilization,4,5 cell–cell interactions6, protein degradation, and most crucially, in cell
signaling.7 However, in tumor cells, some of these glycans tend to be over-, under-, or
newly expressed and these alterations can often make the tumor cells grow, divide and
metastasize differently.3 This phenomenon was first discovered by Meezan et al. in
1969 where they showed that there is a marked decrease of membrane sugars,
especially sialic acid and N-acetylgalactosamine, following SV-40 virus transformation.8
This abnormal expression in glycosylation is found in cancer9,10, retrovirus infection,11,12
and other diseases13. Another feature of tumor cells is the aberrant production of certain
glycolipids and glycoproteins. In epithelial tumors, mucin glycoproteins, which contain
dense clusters of O-linked glycans, are often overproduced. As such, mucins are used
as diagnostic markers of cancer and can serve as scaffolds for most of the cancerassociated glycans shown in Figure 1.1.14 In addition, cancer cells can overexpress
gangliosides, which are glycosphingolipid-containing sialic acids. For example, complex
gangliosides such as GD2, GD3, and fucosyl GM1, as shown in Figure 1.1, are shown
to be overproduced in small-cell lung carcinomas, neuroblasts and melanomas.15
Although it is apparent that tumor cells have aberrant glycosylation, there is no one
single change that distinctly differentiates normal and malignant cells.

3

Table 1.1

Expression of cancer glycans on malignant tissues16,17

Cancer
Glycan

Malignant Tissue
Ovary Pancreas Blood Breast Colon Brain Prostate Skin

Lung

sLex

X

X

X

X

sLea

X

X

X

X

X

X

X

X

X

X

X

sTn

X

TF

X

Ley

X

X

X

X

X

X

Globo H

X

X

X

X

X

X

PSA

X

GD2

X

X

X

X

X

GD3

X

X

X

X

X

Fucosyl
GM1
GM2

X
X

X

X

X

X

4

X

X

X

X

Each type of cancer tissue is defined by a set of variation in glycan expression as
shown in Table 1.1. For example, sialyl Lewis X (sLex) is associated with the metastasis
of B16 melanoma cancer;18 carbohydrate ligand binding to E-selectin controls the
extravasation of cancer cells and organ selectivity of metastasis; 19 sialyl Lewis a (sLea)
binding to selectin and is involved in the extravasation of human colorectal carcinoma
cells;20 endothelial cell adhesion, often controlled by carbohydrate–selectin binding, is
correlated with cancer metastasis;21 and the presence of sLea on cancer cells is
correlated with risk of cancer metastasis.22 This occurrence is medically significant as it
highlights opportunities for therapeutic and diagnostic approaches23.
As discussed above, glycans tend to be over-, under-, or newly expressed in
tumor cells. These changes often arise due to the altered glycosyltransferase levels in
cancerous cells, which modifies the core structure of N-linked and O-linked glycans.
Glycosyltransferases, enzymes that form the glycosidic bonds between sugar units,
produce an increased enzyme level that often results in an increase in the size and
brancing of N-linked glycans that in turn cause an increase in global sialylation.24 In
addition to changes in the glycan core structure, modifications of the terminal structures
are also linked to diseases. In tumor cells, glycosyltransferases involved in linking
terminating residues on glycans are more active leading to overexpression of certain
terminal glycans. Common examples of these terminal glycan epitopes displayed on
malignant cells are sialyl Lewis X (sLex), sialyl Tn (sTn), Globo H, Lewis Y (Ley) and
polysialic acid (PSA)10,15a,25 as shown in Figure 1.1. These glycans are present in
malignant tissues in the brain, breast, colon, and prostate etc. as shown in Table 1.1.26
5

A vital technique in the detection of these glycoproteins in diagnostics is the
immunoassay for carcinoembryonic antigen (CEA). CEA, a tumor-associated mucin
antigen, was first described as a colon cancer marker in 1965 by Gold and Freedman.27
When isolated, CEA is a glycoprotein consisting of ~60% carbohydrate and a molecular
mass of ~180–200 kDa.28 Most of the carbohydrate is composed of mannose, galactose,
N-acetylglucosamine, fucose, and sialic acid.28 CEA levels in mammalian systems are
helpful in monitoring response to treatment and in determining whether there is
possibility of relapse. The CEA test monitors serum levels of an antibody specific for a
cancer-associated glycan, sLea.29 In addition to colon cancer, it is also used as a marker
for other forms of cancer, including cancers of the rectum, lung, breast, liver, pancreas,
stomach, and ovary. Elevated levels of CEA in the blood exhibit a strong, positive
correlation with an increased risk of relapse and metastasis. The CEA test is used to
monitor CEA levels in colon cancer patients, and although it has proven to be valuable,
tests like these have their drawbacks because they are unstable towards rigorous use,
expensive, and difficult to produce. Other serum markers, such as CA12530 and
prostate-specific antigen,31 reveal aberrant glycosylation in ovarian and prostate tumor
tissues. However, for many cancers, there are no serum markers and the tissues must
be analyzed directly. Existing methods requires surgical biopsy of tumor tissue followed
by histological analysis with lectins and monoclonal antibodies. Hence, viable
alternatives for detection of glycans are being actively pursued.32
An interesting future direction to detect aberrant glycosylation is by using probes
for image contrast.33 As mentioned above, mucin glycoproteins are overproduced in
6

epithelial tumors. Specifically, underglycosylated MUC1 antigen (uMUC1) is highly
overexpressed in various human epithelial cell adenocarcinomas and is an early marker
of tumorigenesis.34 The protein portion of uMUC1 can be recognized by a specific
peptide (termed EPPT1) derived from a monoclonal antibody. 35 Epenetos and coworkers developed an EPPT1 based probe that is capable of monitoring breast cancer
in vivo.35b More recently, Dai and co-workers synthesized an EPPT1 conjugate that can
be used for magnetic resonance and optical imaging.36 Experiments with this new probe
showed promising results as positive tumor models showed accumulation of probe in
the tumor tissues while there was very low signal in uMUC-1-negative tumors. However,
uMUC1-specific imaging targets the underglycosylated protein, not the carbohydrate
directly.
This thesis describes work towards developing a method that would allow for
effective detection of glycans. Boronic acids are known for forming strong, reversible,
covalent bonds with 1,2 and 1,3 cis-diols on many sugar molecules.37 These boronic
acids-based lectin mimics are cheap, easy to synthesize and stable towards rigorous
use. Hence, we believe that they can be used as lectin mimics to detect aberrant
glycosylation in a small molecule microarray, which will be discussed in further detail in
Section 1.3.

1.2

Types of Receptors and Sensors for Saccharide Binding
Receptors and sensors for carbohydrate binding can be classified into four

categories: (1) antibodies,38 (2) lectins,39 (3) aptamers based on nucleic acids,40 and (4)
small molecule lectin mimics.41 Antibodies are traditionally used in the recognition of a
7

litany of analytes including carbohydrates. However, they are not used in large-scale
arrays due to cost and stability. Currently, lectins are the most available tools used in
research for carbohydrate recognition but they often have issues with cross-reactivity.42
Hence, it is important to develop new alternatives that possess: (1) high affinity, (2) high
specificity, and (3) are suitable for high throughput analysis. This allows for accurate
and precise study of carbohydrate changes at the glycome level. In order to fulfill these
requirements, there have been major recent developments in fluorescent sensing
methods for carbohydrates for a variety of applications. To this end, small-molecules
and “polymeric binders” have been actively developed. One significant example is the
use of boronic acid-based carbohydrate sensors, such as boronolectin, which is a
specific term for peptides containing boronic acids. There are small molecule
boronolectins (SBL), peptidoboronolectins (PBL), and nucleic acid-based boronolectins
(NBL).
The first phenylboronic acid (PBA) was synthesized by Michaelis and Becker in
1880.43 However, it was 74 years before scientists discovered the ability of boronic and
boric acid to bind with diols. Later publications detailed the studies of a variety of diols
and their binding interactions with boronic and boric acid 44,45. In 1954, Kuivila and his
co-workers noticed that polyols and saccharides were soluble in boronic acid solutions,
and they suggested the formation of a cyclic ester.46 This result agreed with the known
ability of borates to interact with hydroxyl compounds. It was in 1959 that Lorand and
Edwards reported the first quantitative study of the binding constants between several
compounds containing diols and PBA.47
8

Boronic acids have been known to form strong and yet reversible covalent bonds
with 1,2- and 1,3-substituted Lewis base donors such as hydroxyl, amino, and
carboxylate groups. This interaction with diol or alcohols results in boronic esters
(neutral trigonal boron) or boronate esters (anionic tetrahedral boron) based on the
oxidation state of the central boron atom. All these properties have been studied and
explored extensively in research as it allows for boronic acid compounds to be used as
lectin mimics, as nucleotide and carbohydrate transporters, and as affinity ligands for
the separation of carbohydrates and glycoproteins.48 As shown in Figure 1.2, the
boronic acid (1) has an empty boron orbital that allows for reaction with a protic solvent
to form an anionic tetrahedral boronate (2) with the release of a proton. Upon reaction
with the diol moiety, the boronic acid is converted into a boronic ester (3), which is
similar to boronic acid because it can react with a water molecule, release a proton, and
become a boronate ester (4). The equilibria for the formation of the anionic boronate
complex is defined as Ktet, and the formation of a boronic acid complex is defined as
Ktrig. In general, binding with a diol lowers the pKa of the boronic acid.37

9

Figure 1.2.

Binding of phenylboronic acid with a diol

Figure 1.3. Overall binding of phenylboronic acid with a diol

Figure 1.4. Equilibria for ortho-aminomethylphenylboronic acids
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The binding of boronic acids to diols can be interpreted one of two ways. One
way is to look at individual chemical reactions and the binding between the trigonal
boronic acid and the diol or the binding between the tetrahedral boronate and the diol as
shown in Figure 1.2. In this case, Ktrig represents the binding constant between the
trigonal boronic acid and the boronate ester; and Ktet shows the equilibria between the
tetrahedral boronate and the boronate ester anion. The binding of boronic acids can
also be described in Figure 1.3, which shows the overall binding equilibria instead of the
individual reactions. In this case, Keq is used to describe the overall binding constant,
which is an apparent binding constant but is directly relevant to the equilibrium between
a sensor and a carbohydrate.
In order to develop a practical boronic acid-based carbohydrate sensor, it is vital
that binding can occur at physiological pH. However, since the reported pKa of
phenylboronic acid is 8.8, a design to lower the pKa of boronic acid is necessary for
strong binding to occur. B–N bond formation, when functionalized in a relative 1,5
position, acts as a special boronic acid-based sensor, as was shown by the work of
Wulff49 and Shinkai.50 Wang and co-workers have studied in detail how the B–N bond
changes in character as it forms complexes with carbohydrates. 51 These results were
further supported by structural work from the Anslyn lab.52 A method, developed by
Wulff, used a neighboring aminomethyl group as shown in Figure 1.4. The pKa for the
second stepwise protonation in water of ortho-aminomethylphenylboronic acids was
reported by Wulff53 and Anslyn, Canary, and co-workers54 to be 5.3.
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Figure 1.5. Mechanism of sugar sensing by the viologen–boronic acid system.

Figure 1.6. Dye displacement reaction of the adducts between boronic acid
derivatives and Alizarin Red S (ARS) for glucose sensing.
Since boronic acids are able to react with diols and single hydroxyl groups, they
are the most commonly used moieties for the construction of binders for carbohydrates,
which contain many hydroxyl groups. One of the most common techniques employed is
12

the use of fluorescent sensors. An example of a small molecule boronic acid sensor for
saccharide is the viologen bisboronic acid system developed by Singaram and coworkers.55 The system uses anionic fluorescent dyes in combination with boronic acid
as a chromophore and a recognition unit. Viologen is a dye that is considered to be
electron deficient and redox sensitive. A mixture of substituted viologen boronic acid
and fluorescent anionic dye solution results in a nonfluorescent complex due to stacking
and quenching presumably due to charge transfer.55b Once bound to a sugar, the
boronic acid moieties are converted to their anionic form, which combined with the
bulkiness of the molecule results in dissociation of the nonfluorescent complex and
triggers an increase in fluorescence intensity as shown in Figure 1.5. The sensitivity of
the system can be adjusted by modifying the ratio of the anionic dye 8-hydroxypyrene1,3,6-trisulfonic acid trisodium salt (HPTS) and the boronic acid-substituted benzyl
viologens (BBV) recognition unit.
Another example of fluorescent sensors is the use of alizarin and its
derivatives.56 A displacement of binding between boronic acid derivatives and diols
containing fluorescence dyes such as alizarin or Alizarin Red S (ARS) by a target
saccharide as shown in Figure 1.6, which has been used to develop new sensors.57
Alizarin and their derivatives normally provide a very weak emission and their
fluorescence intensities are turned on when forming adducts with boronic acids. When
diol-containing compounds are added into the alizarin-boronic acid mixture, the alizarin
derivatives are displaced and the fluorescence signals are turned off. The decreasing
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degree of fluorescence intensity depends on the concentration of the diol-containing
compounds added.
Recently, there has been more interest in the design of nanoparticulate materials
since they were found to have several advantages owing to their small size and high
surface-to-volume ratio.58 Larpent and co-workers developed a system of boronic acidfunctionalized

nanoparticles

for

use

as a

re-usable

optical

nanosensor for

carbohydrates.59 It is believed that boronic acid-functionalized nanoparticles can
possibly provide valuable supports for the optical detection, the transport, or the
separation of carbohydrates. They reported on the synthesis of boronic acid
functionalized nanoparticles and the study of their diol binding capacity. The catechol,
ARS, and the boronic acid-functionalized nanoparticles afford an optical colored
nanosensor. This nanosensor is then used for fructose binding and detection in a
competitive assay. As mentioned earlier in the section, the binding of sugar is
evidenced by a color change. The boronic acid functionalized nanoparticles are formed
by reacting 3-aminophenylboronic acid (APBA) with NL-CH2X at room temperature, as
shown in Figure 1.7. The nanosensor allows the visual detection of fructose as shown in
Figure 1.8. The binding of fructose to boronic acid-functionalized nanoparticles is easily
observed by the color change of NL–B(OH)2–ARS mixture from orange to burgundy due
to released ARS. When titrations were performed with increasing concentrations of
fructose, it was evident that the ARS was being displaced with fructose due to the
absorbance change. However, when the same titration was performed with glucose, it
does not perturb the ARS-supported boronic acid equilibrium even at high
14

concentrations. Due to this interesting phenomenon, Lapert and co-workers went on to
discover applications for the boronic acid-functionalized nanoparticles as it allows for
selective separation of fructose from mixtures.

Figure 1.7. Preparation of boronic acid-funtionalized nanoparticles

Figure 1.8. Competitive assay: binding of the dye (ARS) and dissociation in the
presence of a carbohydrate.
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1.3

Microarray Analysis of Binding between Boronic Acids and
Glycoproteins
Over the past two decades, microarray analysis has transformed the life science

research landscape. Microarray is a technique that can screen multiple reagents
simultaneously with minimal consumption of sample. Essentially, it is a multiplex lab-ona-chip. An example of a scanned microarray slide with a fluorescence intensity gradient
is shown in Figure 1.9. The technology itself was first used in DNA assemblies on chips,
but shortly thereafter, it was possible for researchers to sequester small molecules60
and then proteins61 for rapid analysis. By now, microarray technology has progressed to
the point where we can examine a host of other biomolecules, including membrane
proteins,62 carbohydrates,63,64 and peptides,65 as well as complex structures such
tissues66 and even live cells67 on arrays. It is noteworthy how a single technology
platform has developed for so many diverse applications. In comparison to microtiterbased assays, microarrays are high-throughput and offer a flat surface for the washing
and incubation steps. This design concept makes it possible to process thousands of
assays quickly and in a less costly manner by reducing the amount of expensive
reagents required.

16

Figure 1.9. Image of scanned microarray glass slide with fluorescence intensity
gradient

Microarrays can be classified into two general types, biochips (biomicroarray)
and chemical microarray (small molecule microarray).68 Biochips are arrays of biological
components, such as protein, DNA, cell, and tissue. Chemical microarrays are arrays of
organic compounds including small organic molecules, peptides, and sugars. In 1999,
MacBeath and Schreiber published the first small molecule microarray research. They
immobilized thiolated compounds onto maleimide-derivatized slides through a thioether
bond and screened them against a series of model proteins. 60 Chemical microarrays
have a wide variety of applications, ranging from drug and biomarker discovery to
disease detection and profiling.69 For example, chemical microarrays are used in
modern drug discovery research to study the interaction between small molecules and
biological targets.70 Figure 1.6 shows the interaction of amino-modified DNA with an
epoxysilane glass slide from Schott Nexterion®.
17

Figure 1.10. Immobilization chemistry of primary amine to epoxysilane glass slides

As compared to DNA and protein microarrays, the development of chemical
microarrays has progressed more slowly.71 One reason for this is that, unlike certain
biomicroarrays, there is no general linking technology that can be applied to immobilize
different compounds containing different functional groups on the same glass slide. A
litany of strategies has been developed to fabricate chemical microarrays. For example,
stable carbohydrate microarrays can be fabricated using Michael addition, 72 Diels–Alder
reaction,73 Staudinger ligation,74 click chemistry,75 Schiff base formation,76,77 and amide
bond formation.78,79 The detection methods for microarray has matured and extended
beyond fluorescent labels, to include label-free optical impedance measurements,80
surface plasmon resonance81 and mass spectrometry-based techniques.82 Lin and coworkers developed a novel and straightforward carbohydrate microarray through
boronate formation.83 Boronic acid forms a stable but reversible complex with cis 1,2- or
18

1,3- diols of carbohydrate, and this allows it to be used as a glycol-targeting probe in
numerous applications.48a,

48f, 84

They reported the use of an aldehyde-functionalized

slide that was reacted in solution to produce a boronic acid-functionalized slide that
would provide a simple and straightforward way of attachment of a litany of unmodified
carbohydrates onto the slide surface. The carbohydrates were then probed with biotinlabelled lectins or antibodies and then detected by Cy3-streptavidin or Cy3-conjugated
secondary antibodies. 3-Aminophenyl boronic acid (APBA), a cheap and readily
available boronic acid was selected to implement the carbohydrate microarray. This
developed method is suitable for all sizes of carbohydrates besides monosaccharides.
The reason is that the hydroxyl groups involved in lectin recognition could be occupied
by the boronic acid. This method is highly convenient as it circumvents the modification
of sugar molecule before immobilization which is often tedious and time consuming.
Another notable strategy in glycomics, i.e. the high throughput analysis of
carbohydrates, is the use of lectin microarrays.85 Lectin microarrays are a form of
protein microarray that utilizes glycan-binding proteins that have proven to be very
effective for the high-throughput analysis of glycans.86 However, the majority of lectins
being used are proteins isolated from plants. These plant lectins are isolated and
purified from natural resources, which often result in inconsistent activity and availability
due to differences in purification and seasonal changes. In addition, most plant lectins
exist as glycoproteins so the lectins themselves could serve as receptors for
carbohydrate-binding proteins leading to false positives. To resolve these issues, Mahal
and co-workers set out to create a recombinant lectin with bacterially- derived lectins for
19

use in microarray technology.85 They cloned, expressed and purified a small panel of
lectins as N-terminal GST–His6 fusions with no noticeable effects on specificity and
provided the possibility of an oriented microarray. In microarray analysis, the simple
lectin panel was able to distinguish between both glycoprotein samples and cell lines,
supporting the idea that a broader lectin panel may be useful for both diagnostics and
carbohydrate analysis. This technology is highly efficient as it allows for rapid
assessment of carbohydrates using minimal sample amounts (<1 μg).86 By
standardizing the conditions for cloning, expression, and purification of bacterial lectins,
it is possible for us to create a large, well-defined lectin library for the rapid analysis of
complex carbohydrates.

1.4

FRET-Based Detection
In addition to microarray technology, detection using Förster Resonance Energy

Transfer (FRET) is also often used the study of carbohydrates. In order to characterize
and detect the density of glycosylated surfaces, an efficient method is needed that
offers high resolution in identifying clusters of dense glycans on cell surfaces. This is
useful in lipid rafts because cell membranes have regions that are concentrated with
specific components, such as sphingolipids, that result in areas of dense
glycosylation.87 These regions have high signaling activity in cells, and it is important
that they be characterized. To this end, we designed carbohydrate binding boronic acid
receptors derivatized with FRET.88
FRET is commonly applied in biology and chemistry and has been used to
measure distance and detect molecular interactions in a number of systems. In this
20

sense, FRET has been used to provide information about protein conformation because
it measures distances between domains in a single protein. 89 Applied in vivo in living
cells, FRET has given us the opportunity to explore the location and interactions of
genes and cellular structure such as integrins and membrane proteins by using variation
of the Green Fluorescence Protein (GFP).90 In addition, FRET can be used to obtain
information of crucial biological pathways and is also used to study lipid rafts in cell
membranes.91
FRET describes the energy transfer between two fluorophores. This mechanism
was first discovered by the German scientist Theodor Förster in 1948.92 When
employing FRET, a donor and an acceptor are involved. When a donor fluorophore is
excited, it transfers energy to an acceptor in close proximity, and this allows for the
transfer of energy through nonradiative dipole–dipole coupling as shown in Figure 1.11.
When choosing FRET pairs, it is a requirement that the emission spectrum of the donor
overlaps with the absorption/ emission spectrum of the acceptor. FRET can be an
accurate measurement of proximity at very short distances (10–100 Å) and highly
efficient if the donor and acceptor are within the Förster radius, which is typically 3–6
nm.93 The technique itself is very sensitive and provides high resolution because the
rate of energy transfer of FRET is dependent on the inverse sixth power of the distance
between the donor and acceptor. Thus, in domains of dense glycosylation, we would
observe an increase in acceptor emission and decrease of donor emission.94 In areas of
sparse glycoslyation, there should be little to no background acceptor emission. Hence,

21

we expect to detect regions of heavy glycoslyation with high resolution by using this
FRET-based assay.

Figure 1.11. FRET-based assay for the detection of carbohydrate clustering on
surfaces.
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Chapter 2:

Design and Synthesis of a Boronic Acid Lectin
Mimic to study Carbohydrate Binding using
Microarray Analysis and FRET

2.1 High-throughput Microarray Analysis
2.1.1 Research Design
In pursuing a boronic acid-based carbohydrate sensor, compound 2.3 (Figure
2.4), that is effective for microarray analysis, certain characteristics had to be
incorporated. First, the final compound must have a terminal amine to cleave open the
epoxides on the microarray glass slide to allow for attachment to the glass surface. Next,
a phenylboronic acid is needed to facilitate binding to polyol compounds. An ethylene
diamine linker was included to extend the distance between the boronic acid and the
terminal amine. The aminomethyl group attached to the phenylboronic acid lowers the
pKa of the phenylboronic acid and allows for better binding at physiological pH. 49a
Three different polyol compounds with fluorescent capabilities were selected for
microarray analysis with boronic acid-based sensors: alizarin, tetramethylrhodamine
tagged avidin, and mucin. Alizarin, or 1,2-dihydroxyanthraquinone, was used as a
model to detect binding between catechols and boronic acids as catechols are known to
have higher binding affinities as compared to sugars.95 Upon binding with boronic acid
moieties, alizarin becomes fluorescent as shown in Figure 2.1 and allows for direct
detection of fluorescence.96 Alizarin is an efficient model as it is cheap and commercially
available. The microarray analysis results provided us with a range of concentrations of
boronic acid-based sensors where we believe the fluorescence intensity to be
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representative of binding between the sensor and catechol. Glycoproteins such as
avidin and mucin were chosen to detect binding between sugars and boronic acids.
Binding of avidin and mucin to slide surfaces for detection are shown in Figure 2.2 and
2.3. Glycoproteins were selected instead of simple sugars because they offer the option
of multivalent binding sites. Generally, a glycoprotein contains many glycan chains and
numerous kinds of carbohydrates. For example, Mucin1 (MUC1) is a glycoprotein with
extensive O-linked glycosylation of its extracellular domain and contains sialic acid. 14
Hence, the boronic acid-based sensor on the slide surface would have multiple
opportunities to detect the glycoprotein.

Figure 2.1

Binding of a boronic acid with alizarin and a 1,2-diol
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Figure 2.2. Binding of alizarin and avidin to microarray slide surface

Following

the

recognition

of

alizarin,

we

explored

the

detection

of

tetramethylrhodamine-tagged avidin. This is essential as it gave us an opportunity to
directly investigate the binding of the glycoprotein with the boronic acid-based sensor as
shown in Figure 2.2. However, fluorophore-tagged glycoproteins do not exist in nature
and to accurately depict the binding of glycoprotein with our boronic acid-based sensor,
we selected mucin1 for microarray analysis. Mucins line the epithelial cells in the lungs,
stomach, intestines, eyes and several other organs.34b Overexpression of MUC1 is often
associated with colon, breat, ovarian, lung and pancreatic cancers. 97 Upon printing the
boronic acid-based sensor on the microarray slide surface, we incubated the supergrids
with the mucin1 glycoprotein. Unlike the tetramethylrhodamine-tagged avidin, mucin1 is
not fluorescent and antibodies are needed for detection. As shown in Figure 2.3, the
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primary antibody, MUC1 antibody, and secondary antibody, Cy3-tagged goat-anti-rabbit
antibody, binds to the MUC1 glycoprotein and the fluorescence is then detected to
affirm binding.

Figure 2.3. Binding of mucin1 to microarray slide surface followed by tagging with
primary and secondary antibodies for detection
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2.1.2 Research Synthesis of Compound 2.3
The final synthetic route to construct compound 2.3 is shown in Figure 2.4. It
begins with the mono-Boc protection of commercially available ethane 1,2-diamine to
produce compound 2.1. The free amine is then coupled to 2-formylphenylboronic acid
via a reductive amination to produce compound 2.2. The Boc group was then
deprotected by using trifluoroacetic acid to yield the trifluoroacetate-ammoium salt 2.3.

Figure 2.4

Synthesis of final product 2.3
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2.1.3 Results and Discussions
As mentioned above, boronic acids can form a stable but reversible complex with 1,2and 1,3 diols of carbohydrate by formation of a boronate ester in aqueous media at
room temperature.47 Herein, we describe the utility of microarray analysis for using
boronic acids as lectin mimics to detect certain carbohydrate structures. Compound 2.3
was printed onto epoxide-functionalized glass slides purchased from Schott Nexterion ®.
The amine of the ethylene diamine linker cleaves open the epoxides on the glass
surface to form covalent bonds when immobilized with the basic print buffer (phosphate
buffered saline (PBS), pH 8.5 and borate buffer, pH 9). On the slide, several supergrids
are usually printed, and 12 different concentrations of each boronic acid will be on each
supergrid. This is then followed by washing and blocking of the unreacted slide surface
and then incubation with the polyol compounds.

Figure 2.5

Left: Robotic pin printer holding 32 pins. Right: Close up image of a pin.
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Using the SDDC-2 robotic printer from ESI, compound 2.3 was printed onto
epoxide-functionalized glass slides. The pin on the robot has an uptake volume of 0.25
μL/ sample channel, a tip size of 75 μm, and a delivery volume of 600 pL. An image of
the pin and printhead is shown in Figure 2.5. Several different buffers were used when
spotting. We first attempted to use tris(hydroxymethyl)aminomethane (TRIS) buffer but
that proved to be ineffective, and we postulated that the buffer contains a free amine
group that could possibly compete with the boronic acid for reacting with epoxy
functional groups. Borate buffer at pH 9 and PBS at pH 8.5 were tried out as print
buffers and both provided reasonable results as shown in Figure 2.6–2.9. After
overnight incubation, the printed slides were washed thoroughly to remove any unbound
boronic acid. The slides spotted with borate buffer were washed with borate buffer
containing 0.05% Tween-20 at pH 9 and the slides spotted with PBS would be washed
with PBS with 0.05% Tween-20 at pH 8.5.
To avoid non-specific interaction between the diol moiety and the slide surface, it
is essential to block the slide surface. Blocking was initially done with ethanolamine
block buffer, but high fluorescence background was observed. Diethylamine block buffer
showed better results and was used for subsequent assays. After an hour of blocking,
the slide was washed thoroughly to remove any traces of block buffer and then dried.
The slides spotted with borate buffer were incubated in a solution of buffered alizarin in
methanol, and the slides spotted with PBS were incubated in a solution of alizarin in
PBS. After alizarin incubation, the slides were washed thoroughly to remove any
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unbound compound followed by detection of fluorescence by slide scanning.
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Figure 2.6

Left: Results of 0–200 μM compound 2.3 printed in 20 mM Borate buffer
and 20% DMSO and incubated with 0.1 mM alizarin. Right: Graphed
results of mean fluorescence intensity of each column on the left with error
bars depicting the standard error.
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Figure 2.7

Left: Results of 0–200 μM compound 2.3 printed in 20 mM Borate buffer
and 20% DMSO and incubated with 0.1 mM alizarin. Right: Graphed
results of mean fluorescence intensity of each column on the left with error
bars depicting the standard error.
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Figure 2.8

Left: Results of 0–480 μM compound 2.3 printed in 20 mM Borate buffer
and 20% DMSO and incubated with 0.1 mM alizarin. Right: Graphed
results of mean fluorescence intensity of each column on the left with error
bars depicting the standard error.
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Figure 2.9

Left: Results of 0–1000 μM compound 2.3 printed in 30 mM phosphate
buffer and 20% DMSO and incubated with 0.1 mM alizarin. Right:
Graphed results of mean fluorescence intensity of each column on the left
with error bars depicting the standard error.
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Three different compounds with diol moieties were incubated with the boronic
acid—alizarin, tetramethylrhodamine tagged avidin and mucin 1. Alizarin was used as a
model for the fabrication of the microarray because catechols are known to have higher
binding affinities with boronic acids than carbohydrates. Twelve different concentrations
(0, 10, 20, 30, 40, 50, 60, 80, 100, 120, 160, 200 μM) of each boronic acid in 20 mM
borate buffer with 20% DMSO were spotted on each supergrid, then blocked and
incubated with its respective assay. The maximum concentration was initially capped at
200 μM as a previous study by Lin and co-workers observed plateauing of fluorescence
intensity when the PBA concentration was at 200 μM. However, our results indicate that
this maximum concentration does not apply to our assay.
Incubation with 0.2 mM alizarin in 20 mM borate-buffered methanol showed
positive linear correlation between fluorescence intensity and concentration of boronic
acid. The maximum boronic acid concentration used in printing was then increased to
300 μM, 480 μM, and ultimately to 1000 μM (300 μM and 400 μM were printed with 20
mM borate buffer at pH 9, and 1000 μM was printed with 30 mM PBS at pH 8.5) in order
to achieve a plateau in fluorescence intensity. It was with printing up to 1000 μM that
leveling off in fluorescence intensity was observed. Hence, 12 concentrations (0, 10, 30,
50, 80, 120, 200, 300, 400, 500, 800, 1000 μM) of boronic acids were chosen to be
incubated with tetramethylrhodamine tagged avidin and mucin. Preliminary results with
tagged avidin show that binding between avidin and PBA does occur because
fluorescence spots were observed.
2.1.4 Conclusions and Future Work
32

We successfully used microarray techniques to show that binding between
alizarin and boronic acid occurred on epoxide-functionalized slides. The printing of the
boronic acid-based sensors proved to be the most challenging step in the microarray
analysis. Ultimately, printing with 30 mM PBS with 0.05 % Tween at pH 8.5 proved to be
effective. Blocking of the unreacted slide surface was initially unsuccessful with
ethanolamine buffer but switching to diethylamine buffer rectified the issue. The slides
were incubated with alizarin, tetramethylrhodamine-tagged avidin and MUC1 as shown
in Figures 2.2 and 2.3. The work done with alizarin proved to be successful but the
incubation of the boronic acid-based sensor with tetramethylrhodamine-tagged avidin
and MUC1 requires further optimization.
Preliminary results of microarray analysis with tetramethylrhodamine-tagged
avidin and MUC1 showed that the supergrids were visible, which is a positive indication
of binding. However, unlike Figures 2.6–2.9 of the alizarin slides, a gradient of
increasing fluorescence intensity was not observed. Hence, further optimization of the
conditions is necessary.
2.1.4.1 Problems with Printing
Even though the previously mentioned microarray assays have yielded intital
results, it could benefit from further optimization. One of the biggest problems we have
faced with microarray analysis is inconsistency. The printing of samples on the slide
surface has often proven to be temperamental. Typically, supergrids can be observed
on the glass surface after printing as the printing buffer is an aqueous solution with high
salt content. There are many instances where after printing, no visible spots can be
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seen on the slide. If that is the case, no printing solution has been deposited on the
slide surface. This could be due to many issues 1) The solution being spotted has
evaporated before printing could occur, 2) The solution has clogged the pin tip, 3) The
pin tip could be damaged. The evaporation issue can be addressed by increasing
humidity of the environment while printing, adding high boiling and/or viscous solvents
such as dimethyl sulfoxide or glycerol. In addition to having no spots, a frequent
problem is pin clogging. It appears that during the printing sequence, the pin becomes
clogged and stops depositing solution on the slide surface as seen in Figure 2.10b. This
problem can usually be solved by adjusting the concentration of the buffer. For example,
this phenomenon was a common occurrence when the printing buffer was 50 mM
borate buffer with 0.05% Tween. Attempts were made to solve this problem by
sonicating the pin before every print sequence and carefully air drying the pin, but it did
not improve the printing situation. However, when we tried printing instead with 20 mM
borate buffer with 0.05% Tween, the pin printed perfectly but the spots were hollow in
the center. This could potentially cause inaccurate fluorescence readings. We
postulated that this was because the printed spots were drying out too quickly, so new
printing solutions with 20% DMSO were prepared to resolve this issue. At times, the
spots printed could merge together as shown in Figure 2.10c. When this occurs, a
simple solution such as adjusting the buffer concentration usually solves this issue.
Ultimately, if modifying the printing conditions does nothing to improve the
printing situation, it is possible that the pin is damaged. A convenient way to determine
whether the pin is damaged is to have it print solutions of printing buffers. If the pin is
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able to print grids of buffers with no noticeable difficulty (clogging etc.), then further
modifications should be made to the printing solution.
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a)

b)

c)

Figure 2.10. Image of supergrids as viewed under a microscope a) a well printed grid
where spots appears to be evenly spaced and evenly sized b) a poorly
printed grid where pin clogging occurs c) a poorly printed grid where spots
merged together.

2.1.5 Experimental
Materials
Epoxysilane-coated glass slides (Nexterion slide E) were purchased from
SCHOTT North America). Tetramethylrhodamine tagged avidin (Protein Mods), mucin 1,
mucin 1 antibody and cy3 tagged goat-anti-rabbit antibody were purchased from Novus
Biologicals; other standard chemicals were purchased from commercial suppliers and
used as received. Glass slides were stored in a desiccator to keep them dry.
Methods
Microarray fabrication
Stock boronic acid solution was stored at 5 mM in water and kept at -20 oC in a
freezer. When printing with borate buffer, 12 different concentrations (0, 10, 20, 30, 40,
50, 60, 80, 100, 120, 160, 200 μM) of boronic acids were prepared in a 96-well plate
with 0 μM acting as the control. This was also repeated for printing up to 300 μM (0, 18,
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42, 60, 81, 102, 120, 150, 180, 210, 250, 300 μM ) and 480 μM (0, 9, 24, 39, 60, 81. 99,
150, 198, 270, 360, 480 μM). Initially, printing was done with 50 mM borate buffer but
this clogged the pin, so the concentration of the buffer was lowered to 20 mM. However,
after lowering the concentration of buffer, the spots appeared to be hollow, and that
caused inaccurate fluorescence reading. We postulated that this was because the
printed spots were drying out too quickly, so new printing solutions with 20 mM borate
buffer with 0.05 % Tween at pH 9 and 20% DMSO were prepared. When printing with
PBS, 12 different concentrations (0, 10, 30, 50, 80, 120, 200, 300, 400, 500, 800, 1000
μM) of boronic acids in PBS and 0.05% Tween at pH 8.5 were prepared in a 96 well
plate with 0 μM acting as the control.
Using the standard robotic pin printer, the different solutions of boronic acids
were printed on the epoxide-functionalized glass slides, and each super grid was
printed in a 12 x 10 pattern. After an overnight incubation in a humidifying chamber,
which is essentially a container holding a piece of hot paper towel, the slides were
washed by submerging them in Petri dishes filled with wash buffer and gently shaking
on a waver. The slides printed with borate buffer were washed with borate buffer and
0.05% Tween at pH 9, and the slides printed in PBS were washed with PBS buffer and
0.05% Tween at pH 8.5. The slides were washed 3 separate times with their respective
wash buffer at 5 minute intervals. Blocking was done by gently shaking the slide on a
shaker for 1 hour with the slide in a Petri dish filled with 20 mM diethylamine in 20 mM
borate buffer and 0.05% Tween at pH 9. After blocking, the slides were washed three
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times at 5 minute intervals with their respective wash buffers and then dried with
nitrogen air and used for incubation.
Binding Assays
Alizarin was dissolved in borate-buffered methanol to give a concetration of 0.1
mM alizarin (borate buffer: 20 mM boric acid, 20 mM sodium borate in methanol at pH
8.5). During incubation, the glass slide would be submerged in 50 mL of buffered
alizarin in a Petri dish for 1 hour. The Petri dish was covered to prevent evaporation of
solvent. The Petri dish used for incubation was left on a flat surface and not placed on a
waver as preliminary results showed that shaking provided unsuccessful results. After
incubation was complete, the slides were washed 3 times with their respective wash
buffer and 3 more times with water. Each wash with wash buffer took approximately 5
minutes and each wash with water took approximately 15 minutes. The slides were
dried completely using nitrogen air and then scanned immediately to obtain results.
Data Analysis
Using the GenePix® 4000B microarray scanner from Axon instruments, the
fluorescence intensities of microspots were quantified. The array reader has a 532 nm
wavelength laser which scanned the slide and showed the image of the supergrid. The
spot with no boronic acid was used as the control. The spots which showed anomalous
results such as abrupt lower or higher fluorescence were removed from the analysis.
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2.2

FRET Detection

2.2.1 Research Design
In order to characterize and detect the density of glycosylated surfaces, we set
out to design carbohydrate-binding boronic acid receptors derivatized with FRET pairs
as shown in Figure 2.11. To achieve this goal, several fluorophore-tagged boronic acids
were synthesized by my co-workers and me. Coumarin-tagged (synthesized by me) and
NBD-tagged (synthesized by Chí-Linh Đỗ-Thanh) boronic acids, 2.5 and 2.6 in Figure
2.12, respectively, were used as a FRET pair because of overlap in emission and
excitement in donor and acceptor. Compound 2.5 was synthesized via a coupling
reaction that involved generation of a common boronic acid precursor appended to an
amine functionality, which can be modified via specific reactions, such as reductive
amination or coupling, to introduce different fluorophores, which entails modification in
the final step. Another option would be to couple the amine to the fluorophore first,
followed by addition of the boronic acid, as that would simplify the purification step. The
two synthetic routes are shown in Figure 2.13 as 2.13A and 2.13B.
In addition, two different guests were involved in FRET studies, a catechol
compound, 2.7 in Figure 2.12, (synthesized by Manpreet Kaur Cheema) and a mannose
compound, 2.8 in Figure 2.12, (synthesized by Irene Abia). The idea of using divalent
guests arose because we wanted to create a system that could imitate cell-surface
carbohydrate clustering involving sugar molecules in the near vicinity. In order to
activate FRET, the diol moieties on the mannose sugars or catechol derivatives were
connected via a linker, as shown in Figure 2.11, to bind the donor and acceptor on the
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same molecule bringing them into closer proximity. As reported in literature,95 the
binding affinities of boronic acids towards catechol are higher than that for the mannose
sugar counterparts.

Figure 2.11. Schematic Representation of fluorophore-tagged boronic acids binding to
guest

40

2.2.2 Research Synthesis
To synthesize the coumarin-tagged boronic acid, compund 2.5 as shown in
Figure 2.7, two different synthetic routes were pursued as shown in Figure 2.13. The
synthesis of coumarin-tagged boronic acid receptor 2.5 was initiated via mono-Boc
protection of ethylenediamine. Afterwards, two different synthetic routes were attempted
to observe which one was more efficient. The mono-Boc protected ethylenediamine
was coupled with 2-formylphenylboronic acid via reductive amination to produce 2.2.
Boc deprotection of 2.2 using trifluoroacetic acid followed by EDC coupling gave
compound 2.5. This method provided us with an overall lower yield as purification of the
polar compound 2.2 proved to be troublesome. Another option was for us to install the
phenylboronic acid in the last step to make purification easier. The mono-Boc protected
ethylenediamine was first coupled to coumarin-3-carboxylic acid to give compound 2.4
by EDC coupling. This was followed by Boc deprotection using trifluoroacetic acid and a
substitution reaction with 2-bromomethylphenylboronic acid.

Figure 2.12. Target fluorophore tagged donor and acceptor and guests.
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Figure 2.13. Synthesis of coumarin-tagged boronic acid receptor via routes 2.13A and
2.13 B.

Figure 2.14. Synthesis of pyrene-tagged boronic acid receptor.
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Attempts were made to synthesize pyrene-tagged boronic acid receptors for
FRET detection as shown in Figure 2.14. Pyrene was selected for this purpose as it can
function as both the donor and the acceptor. Unfortunately, the coupling of compound
2.1 to 1-pyrenebutyric acid to yield compound 2.9 proved to be problematic. 1-Ethyl-3(3-dimethylaminopropyl)carbodiimide

(EDC)

coupling,

when

used

with

4-

dimethylaminopyridine (DMAP) and N-methylmorpholine (NMM), produces compound
2.9 but at a low yield of 20%. It is apparent that further optimization of reaction
conditions is required.

2.2.3 Binding Studies
The fluorescence titration of coumarin and NBD-tagged boronic acid donor/
acceptor were meant to be completed with various diol-containing guests ranging from
mannose- to catechol-based diol guests. During initial studies, the most promising
results were obtained with HEPES buffer near neutral pH, and this was used for the
binding titrations conducted.
Titrations were conducted using a fluorimeter to observe any fluctuations in
fluorescence intensities of the donor and acceptor. We expect to see a gradual
decrease in the coumarin emission signal and a gradual increase the emission intensity
of the acceptor NBD molecules upon titration with guests. Compound 2.7 solutions
prepared in HEPES buffer (5 mM at pH 7.4) were titrated against donor/acceptor
solution (13.6 μM) and reasonable results were obtained as shown in Figure 2.15.
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However, it was odd that the emission of NBD increased and then decreased. Thus, it is
important that more work is done to optimize the conditions of FRET.
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Figure 2.15 FRET-based fluorescence studies
a) FRET donor–acceptor signal
b) Decrease in fluorescence signal of Coumarin
c) Increase and then decrease in fluorescence signal of NBD
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2.3

Experimental

Tert-Butyl (2-aminoethyl)carbamate (2.1)

Ethane-1,2-diamine (12.0 mL, 179 mmol) was dissolved in dichloromethane (20 mL)
and stirred. A solution of di-tert-butyldicarbonate (3.91 g, 17.9 mmol) in dichloromethane
(40 mL) was then added dropwise via an addition funnel. The mixture was stirred
overnight at room temperature and then extracted with dichloromethane (2 x 50 mL)
from saturated aqueous sodium carbonate (50 mL). The combined organic layers were
dried over magnesium sulfate, filtered and concentrated to give the product 2.1 (1.99 g,
76%) as a yellow oil. Characterization matched prior literature.98
1

H NMR (300 MHz, CDCl3) δ 4.99 (s, 1H), 3.17 (q, J = 5.9 Hz, 2H), 2.80 (t, J = 6.4, 5.5

Hz, 2H), 1.45 (s, 9H) ppm.
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(2-(((2-((tert-Butoxycarbonyl)amino)ethyl)amino)methyl)phenyl)boronic acid (2.2)

2.1 (0.312 g, 1.95 mmol) and 2-formylphenylboronic acid (0.327 g, 2.14 mmol) are
added to round bottom flask and the flask was stoppered to have the air removed under
vacuum. A nitrogen balloon was attached to the flask and the solution was stirred.
Methanol (25 mL) was then added via a syringe and sodium cyanoborohydride (0.283 g,
4.28 mmol) was added in methanol via a syringe as well. The solution was then stirred
overnight at room temperature, and then concentrated. Purification on a reversed-phase
column (10 g, C18) with gradient elution from 0 to 100% methanol/water gave the
product as a white solid 2.2 (0.247 g, 43%).
1

H NMR (300 MHz, CD3OD) δ 7.45–7.39 (m, 1H), 7.24–7.11 (m, 3H), 4.05 (s, 2H), 3.39

(t, J = 6 Hz, 2H), 2.97 (t, J = 6 Hz, 2H), 1.44 (s, 9H).
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2-((2-Boronobenzyl)amino)ethanaminium 2,2,2-trifluoroacetate (2.3)

Trifluoroacetic acid (7 mL) was added to a solution of 2.2 (0.176 g, 0.597 mmol) in
dichloromethane (7 mL). The reaction mixture was stirred in the dark at room
temperature for 3 hours and then concentrated and dried under vacuum to obtain a
yellow solid of trifluoroacetate salts (0.298 g, 162%). The high yield is due to the leftover
trifluoroacetic acid and will be removed in the next step of the synthesis.
1

H NMR (300 MHz, CD3OD) δ 7.77 (s, 1H), 7.44 (s, 3H), 4.34 (s, 2H), 3.38–3.33 (m, 4H)

ppm.
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tert-Butyl (2-(2H-chromene-3-carboxamido)ethyl)carbamate (2.4)

To a stirred solution of compound 2.1 (0.111 g, 0.705 mmol) in dichloromethane (8 mL)
was added coumarin-3-carboxylic acid (0.1118 g, 0.588 mmol), N-methylmorpholine
(129 μL, 1.18 mmol) and 4-dimethylaminopyridine (0.0718 g, 0.588 mmol). The solution
was

then

cooled

to

0

o

C

and

stirred

for

15

minutes.

1-Ethyl-3-(3-

dimethylaminopropyl)carbodiimide in hydrochloride (0.135 g, 0.705 mmol) then added at
0 oC, and the reaction was stirred overnight while warming to room temperature.
Afterwards, the solution was extracted with dichloromethane (12 mL) and water (20 mL).
After collecting the organic layer, the aqueous layer was washed again with
dichloromethane (20 mL). The organic layers were combined and dried with anhydrous
magnesium sulfate, filtered, and the solvent was removed. Column chromatography
with

silica

gel

and

a

solvent

gradient

of

1%–5%

methanol/

dichloromethane yielded 2.2 (0.124 g, 53%) as a yellow powder.
1

H NMR (300 MHz, CDCl3) δ 9.00 (s, 1H), 8.90 (d, J = 0.7 Hz, 1H), 7.86–7.56 (m, 2H),

7.55–7.23 (m, 2H), 5.20 (s, 1H), 5.09 (s, 1H), 3.60 (q, J = 3.0 Hz, 2H), 3.40 (q, J = 6.0
Hz, 2H), 1.44 (s, 9H) ppm.
HRMS [M+ H]+ calcd: 333.1372, found: 333.1342
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2-(((2-(2-Oxo-2H-chromene-3-carboxamido)ethyl)amino)methyl)phenylboronic acid (2.5)

To a stirred solution of compound 2.2 (0.074 g, 0.214 mmol) in dichloromethane (5 mL)
and acetonitrile (5 mL) was added coumarin-3-carboxylic acid (0.0338 g, 0.178 mmol),
N-methylmorpholine (39.1 μL, 0.356 mmol) and 4-dimethylaminopyridine (0.0217 g,
0.178 mmol). The solution was then cooled to 0 oC and stirred for 15 minutes. 1-Ethyl-3(3-dimethylaminopropyl)carbodiimide in hydrochloride (0.0410 g, 0.214 mmol) then
added at 0

o

C, and the reaction was stirred overnight while warming to room

temperature. Afterwards, the solution was concentrated and then extracted with
dichloromethane (20 mL) and water (20 mL). After collecting the organic layer, the
aqueous layer was washed again with dichloromethane (20 mL). The organic layers
were combined and dried with anhydrous magnesium sulfate, filtered, and the solvent
was removed. Purification on a reversed-phase column (10 g, C18) with gradient elution
from 0 to 100% methanol/water gave the product as a yellow solid 2.5 (0.245 g, 38 %).
1

H NMR (300 MHz, CD3OD) δ 8.87 (s, 1H), 7.88–7.80 (m, 1H), 7.80-7.70 (m, 1H) 7.44

(m, 4H), 7.26 (s, 2H), 7.02 (s, 1H), 4.19 (d, J = 14.6 Hz, 2H), 3.81 (s, 2H), 3.25–3.07 (m,
2H).
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tert-Butyl (2-(4-(pyren-1-yl)butanamido)ethyl)carbamate (2.9)

To a stirred solution of compound 2.1 (0.677 g, 4.23 mmol) in N,N– dimethylformamide
(5 mL) was added 1-pyrenebutyric acid (0.813 g, 0.282 mmol), N-methylmorpholine
(0.612 mL, 2.82 mmol) and 4-dimethylaminopyridine (0.344 g, 2.82 mmol). The solution
was

then

cooled

to

0

o

C

and

stirred

for

15

minutes.

1-Ethyl-3-(3

dimethylaminopropyl)carbodiimide in hydrochloride (0.811 g, 4.23 mmol) was then
added at 0

o

C, and the reaction was stirred overnight while warming to room

temperature. Afterwards, the solution was concentrated and then extracted with
dichloromethane (20 mL) and water (20 mL). After collecting the organic layer, the
aqueous layer was washed again with dichloromethane (20 mL) twice. The organic
layers were combined and dried with anhydrous magnesium sulfate, filtered, and the
solvent was removed. Column chromatography with silica gel and a solvent gradient of
40%–60% ethyl acetate/ hexane yielded 2.9 (0.243 g, 20%) as a yellow powder.
1

H NMR (300 MHz, CDCl3) δ 8.38–8.32 (m, 1H), 8.20–8.08 (m, 4H), 8.04–8.01 (m, 2H),

7.99 (d, J = 2.1 Hz, 1H), 7.87 (dd, J = 7.8, 3.7 Hz, 1H), 3.58 (p, J = 6 Hz, 2H), 3.45 (d, J
= 7.7 Hz, 2H), 2.44–2.32 (m, 2H), 2.32 – 2.16 (m, 2H), 1.62 (s, 2H), 1.47 (s, 9H).
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Chapter 3
3.1

Miscellaneous
Microarray
Synthetic Compounds

Synthesis of N-(4-nitrobenzenesulfonyl)
nitrophenyl) alanine

Analysis

and

alanine and

N-(4-

For a collaborative project with Dr. Robert Compton, we synthesized N-(4nitrobenzenesulfonyl)-L-alanine (3.2a), N-(4-nitrobenzenesulfonyl)-D-alanine (3.2b), N(4-nitrophenyl)-L-alanine (3.3a) and N-(4-nitrophenyl)-D-alanine (3.3b) to study their
circular dichroism (CD) and negative-ion properties.

Figure 3.1.

Synthesis of alanine analogues
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Experimental

N-(4-nitrobenzenesulfonyl)-L-alanine (3.2a) and N-(4-nitrobenzenesulfonyl)-D-alanine
(3.2b) To produce compound 3.2a, an aqueous 1 M sodium hydroxide solution (5 mL)
was added to L-alanine (3.2a, 1.00 g, 11.3 mmol), followed by cooling to 0 °C. 4Nitrobenzenesulfonyl chloride (3.82 g, 16.9 mmol) was next added in small portions,
and the reaction mixture was stirred at rt overnight, followed by washing with ethyl
acetate (2 × 10 mL). The aqueous layer was then acidified with 1 M hydrochloric acid
(10 mL) and extracted with ethyl acetate (15 mL). The latter organic layer was dried with
magnesium sulfate, filtered, and concentrated. Column chromatography over silica gel
with gradient elution from 5 to 20% methanol/dichloromethane gave the product as a
yellow solid (0.71 g, 31%). Enantiomer 3.2b was similarly prepared using D-alanine
(3.1b, 1.01 g, 11.3 mmol), 1 M sodium hydroxide (7 mL) and 4-nitrobenzenesulfonyl
chloride (3.82 g, 16.9 mmol), which yielded 3.2b as a light yellow solid ( 0.831 g, 35%).
1

H NMR (300 MHz, DMSO-d6) δ 8.37 (d, J = 7.1 Hz, 2H), 8.04 (d, J = 7.1 Hz, 2H), 3.68

(q, J = 7.1 Hz, 1H), 1.19 (d, J = 7.1 Hz, 3H).
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N-(4-nitrophenyl)-L-alanine (3a) and N-(4-nitrophenyl)-D-alanine (3b) To produce
compound 3a, 20 mL of N,N-dimethylformamide (DMF) was added to L-alanine (1a,
0.950 g, 10.7 mmol). Potassium carbonate (2.95 g, 21.3 mmol) and potassium iodide
(1.77 g, 10.7 mmol) were then added to the stirring solution. 4-Chloronitrobenzene (3.36
g, 21.3 mmol) was next added in small portions, and the reaction mixture was stirred
and refluxed at 120 oC overnight. Next, the solvent was removed via rotary evaporation.
The crude product was then dissolved in 50 mL of water, acidified with 1 M hydrochloric
acid (20 mL), and extracted with ethyl acetate (2 x 25 mL). The latter organic layer was
dried with magnesium sulfate, filtered, and concentrated. Column chromatography over
silica gel with gradient elution from 1 to 25% methanol/dichloromethane gave the
product as a yellow solid (1.21 g, 54%). Enantiomer 3b was similarly prepared using Dalanine (1b, 0.880 g, 9.90 mmol), 20 mL of DMF, potassium carbonate (2.74 g, 19.8
mmol), tetrabutylammonium iodide (3.66 g, 9.90 mmol) and 4-chloronitrobenzene
(3.12g, 19.8 mmol), which yielded 3b as a yellow solid (0.67 g, 32%). 1H NMR (300 MHz,
Methanol- d4) δ 8.02 (d, J = 9 Hz, 2H), 6.60 (d, J = 9 Hz, 2H), 3.96 (q, J = 9 Hz, 1H),
1.48 (d, J=9 Hz, 3H, –CH3).
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3.2

Carbohydrate Microarray Analysis
For a collaborative project with Dr. David Baker, we will utilize covalent

immobilization of thiol-terminated sugars as shown in Figure 3.2 onto epoxide
functionalized slides. This allows for a very stable glycan microarray for interrogation
with proteins. This project was previously worked on by Irene Abia from the Baker lab.

Figure 3.2. Thiol-terminated mannose used in binding studies.
Using robotic printing technology, thiol-terminated mannose derivatives 3.4a,
3.4b and 3.4c were printed onto epoxide-functionalized glass slides (Figure 3.2) to
achieve covalent immobilization.
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3.2.1 Experimental
3.2.1.1 Materials
Epoxide-derivatized glass slides (Nexterion slide E, SCHOTT North America),
Rhodamine labeled Conconavalin A (Vector Labs), thiol-terminated mannose
derivatives; all other standard chemicals were purchased from commercial suppliers
and used as received. Glass slides were stored in a desiccator to keep them dry.
3.2.1.2. Methods
Printing sugar solutions were made up of sugar, PBS (30 mM phosphatebuffered saline and 0.05% Tween-20) of pH 8.5 and TCEP. The final TCEP
concentration in each prepared sugar solution was 2 mM. On a single glass slide, 12
different concentrations (0, 25, 50,100, 150, 200, 250, 300, 400, 500, 750, 1000 μM) of
each sugar were probed with 6 different concentrations of protein Con A (0, 5, 10, 20,
30, 50 μg/mL, which corresponds to 0, 48, 96, 192, 288 and 481 nM, respectively).
Using the standard robotic pin printer (Virtek ChipwriterTM Professional Arrayer, Figure
20), the different solutions of sugars were printed on epoxide functionalized glass slides.
Each super grid had 3 grids, and each grid was printed in a 12 × 10 pattern. After an
overnight incubation at room temperature, slides were washed by submerging them in
Petri dishes filled with wash buffer (PBS, pH 7.4 containing 0.05% Tween-20) and
gently shaking on a waver for 30 min. To block unreacted epoxides, slides were
submerged in Petri dishes filled with a block solution (50 mM ethanolamine in 100 mM
borate, pH 9.2) and gently shaken for 1 h on a waver. After blocking, the slides were
washed three times by immersing them in Petri dishes filled with PBS buffer (pH 8.4)
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and dried by gentle purging with N2 air. Slides were immediately used for incubation
with protein.
Rhodamine-labeled Con A (5 mg/mL) was diluted in PBS buffer. Six different
concentrations of Con A were obtained: 2, 5, 10, 20, 30 and 50 μg/mL. An incubation
chamber was fabricated by placing a damp, warm paper towel in a covered plastic box.
The IC-16 chamber from Nexterion was used to separate the supergrids. For
incubations, 120 μL of protein solution was applied to each supergrid, and slides were
placed in the incubation chamber and placed on the shaker for 1 h at room temperature.
After incubation, slides were washed three times in Petri dishes filled with wash buffer
for three times with distilled water, and then dried by gentle purging with N2 air to ensure
complete dryness. Each wash was approximately 5 min. The dried plates were scanned
immediately to obtain results.
3.2.2 Preliminary Results

Figure 3.3. Scanned image of glycan microarray with Con A. Monosaccharide 3.4a,
disaccharide 3.4b, and trisaccharide 3.4c. Protein concentrations: 0 μg/mL
(A), 5μg/mL (B), 10 μg/mL (C), 20 μg/mL (D), 30 μg/mL (E) and 50 μg/mL
(F).
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Preliminary results of microarray analysis proved to be successful as increasing
fluorescence intensity is observed with increasing protein concentration and glycan
concentration. Interestingly, the grids incubated with no protein concentration showed
fluorescence and that should not have been the case. However, work remains to be
done as this assay requires that perfectly printed supergrids and the slide shown in
Figure 3.3 has a few grids which were not completed printed. It is necessary that we
improve on and optimize the current conditions.
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